- Open Access
Human Immunodeficiency Virus Type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains
© Brügger et al; licensee BioMed Central Ltd. 2007
- Received: 17 July 2007
- Accepted: 01 October 2007
- Published: 01 October 2007
The Nef protein of Human Immunodeficiency Viruses optimizes viral spread in the infected host by manipulating cellular transport and signal transduction machineries. Nef also boosts the infectivity of HIV particles by an unknown mechanism. Recent studies suggested a correlation between the association of Nef with lipid raft microdomains and its positive effects on virion infectivity. Furthermore, the lipidome analysis of HIV-1 particles revealed a marked enrichment of classical raft lipids and thus identified HIV-1 virions as an example for naturally occurring membrane microdomains. Since Nef modulates the protein composition and function of membrane microdomains we tested here if Nef also has the propensity to alter microdomain lipid composition.
Quantitative mass spectrometric lipidome analysis of highly purified HIV-1 particles revealed that the presence of Nef during virus production from T lymphocytes enforced their raft character via a significant reduction of polyunsaturated phosphatidylcholine species and a specific enrichment of sphingomyelin. In contrast, Nef did not significantly affect virion levels of phosphoglycerolipids or cholesterol. The observed alterations in virion lipid composition were insufficient to mediate Nef's effect on particle infectivity and Nef augmented virion infectivity independently of whether virus entry was targeted to or excluded from membrane microdomains. However, altered lipid compositions similar to those observed in virions were also detected in detergent-resistant membrane preparations of virus producing cells.
Nef alters not only the proteome but also the lipid composition of host cell microdomains. This novel activity represents a previously unrecognized mechanism by which Nef could manipulate HIV-1 target cells to facilitate virus propagation in vivo.
- Lipid Composition
- Lipid Raft
- Virion Incorporation
- Virus Produce Cell
- Particle Infectivity
The Nef protein of Human Immunodeficiency Viruses is a multifunctional protein critical for high virus titers in vivo. Consequently, disease progression in individuals infected with nef deficient viruses is at least significantly delayed [1–3]. These effects are thought to mirror independent activities of Nef that prevent immune recognition of virally infected cells and directly boost the replicative potential of HIV [4, 5]. To achieve such optimized spread in the infected host, Nef manipulates a variety of transport and signal transduction processes in cells infected by HIV-1. Modulation of cellular transport paths by Nef affects the surface presentation of an increasing number of cell receptors like e.g. CD4, MHC class I and II molecules and chemokine receptors [6–9]. Equally wide spread are Nef effects on host cell signalling, including various alterations of the TCR cascade in T lymphocytes. According to an emerging view Nef can act as an intracellular inducer of TCR distal events in the absence of exogenous stimulation while signalling by exogenous TCR stimulation is tuned down in the presence of the viral protein [10–14]. Finally, during production of progeny virus, Nef augments the intrinsic infectivity of cell-free HIV particles by a factor 5–10 via a poorly characterized mechanism [15–17].
Associated with cellular membranes by virtue of its N-terminal myristoylation and additional membrane targeting motifs, a subpopulation of Nef resides in detergent resistant membrane microdomains (DRMs) or lipid rafts [18–23]. Lipid rafts are defined as highly dynamic microdomains in cellular membranes that are enriched in sphingolipids, cholesterol and raft-targeted proteins. This particular lipid and protein composition is thought to facilitate protein-protein interactions to create microdomains with distinct biological properties. Lipid rafts have been implicated as platforms for central cellular processes such as signal transduction and protein trafficking but are also utilized as preferred sites for entry and egress of a number of viruses, including HIV-1 [24–27]. Originally defined as resistant to extraction with cold detergent, the existence of these membrane microdomains in living cells has been subject to intense debates [28–32]. This controversy stemmed primarily from the lack of both, appropriate live cell imaging techniques to visualize such assemblies and detergent-free biochemical purification protocols. Over the past years, the application of new dyes such as Laurdan and the real-time visualization of protein dynamics during signalling processes have largely corroborated the membrane microdomain concept [33–37]. Moreover, our previous lipidome analysis of highly purified HIV-1 particles provided an example of a biological membrane generated in the absence of detergent that displays a lipid composition with striking similarity to DRMs .
Recent studies suggested that DRM incorporation of Nef spatially separates its individual activities in infected cells. The use of mutated Nef proteins that are enriched in DRMs due to an additional palmitoylation signal or that lack a di-lysine motif that facilitates DRM incorporation of the viral protein, respectively, revealed that Nef activities in receptor transport are largely independent of its raft association [19, 21]. In contrast, signal transduction properties of Nef such as the association with the activated form of the cellular Pak2 kinase strictly occurs within membrane microdomains, thus providing spatial compartmentalization of individual Nef activities [19, 20, 39]. This concept is in line with a recent proteomic analysis that revealed significant alterations in the DRM recruitment of TCR machinery by Nef . In contrast, conflicting results exist as to what extent DRM association of Nef determines its ability to enhance virion infectivity. An early report demonstrated that this Nef activity depends on raft integrity of the producer cell and suggested this to reflect the Nef-mediated recruitment of HIV budding structures into DRMs . In line with a role for lipid rafts in Nef-mediated infectivity enhancement, disruption of DRM association of Nef correlates with a loss of infectivity enhancement . However, DRM recruitment of HIV structural proteins was not observed in another study and DRM enrichment of Nef failed to further boost particle infectivity .
The biological properties of Nef were thus far largely explained by its interactions with host cell proteins. A few recent reports however suggest that Nef might also affect biosynthesis and transport of select host cell lipid species. These reports primarily focus on cellular cholesterol and suggest a direct interaction of Nef with this sterol as well as the induction of cholesterol biosynthesis genes by Nef [41, 42]. Via a mechanism specific to macrophages, Nef was also reported to alter cholesterol efflux by interacting with the ABCA1 transporter . These results raised the possibility that Nef might influence not only the protein but also the overall lipid composition of host cell membranes to optimize virus replication. To test this hypothesis, we compared in this study the impact of Nef on the lipidome of HIV-1 virions and T lymphocytes DRMs.
Association of Nef with membrane microdomains is not limiting for its effects on virion infectivity and viral replication
Nef does not recruit HIV Gag into detergent resistant microdomains in infected MT-4 T lymphocytes
To address potential reasons for the Nef-mediated increase in virion infectivity in our experimental system, we performed raft flotation experiments with lysates of MT4 T lymphocytes infected with cell free virus stocks (Fig. 1C). Cells were lysed in the presence of cold Tx-100 and, following a standard raft flotation procedure , equal volumes DRM (DRM) and soluble (S) fractions as well as total cell lysate (L) were analyzed by Western Blotting. The DRM excluded transferrin receptor (TfR) was used as loding control (bottom panel). Only small amounts of Nef were detected in the DRM fraction and the microdomain association of PalmNef was significantly more pronounced. Pr55Gag precursor, processing intermediates as well as fully processed p24CA were detected with the anti-p24CA antibody (upper panel). The low levels of p24CA in DRM fractions do not reflect a processing defect but rather the lack of membrane targeting after physical separation of CA from MA by protease cleavage. No Nef-mediated enrichment of Pr55Gag in DRMs was detected in infected MT-4 T lymphocytes (ratio of DRM-associated relative to total Gag: wt: 39.4%; ΔNef: 51.4%; PalmNef: 36.1%). These results are in agreement with a study by Sol-Foulon et al.  that used HIV-1 infected Jurkat T lymphocytes, however are in conflict with a report on Nef-mediated DRM recruitment of Gag in 293T cells that were transfected with proviral DNA . To assess if this discrepancy stems from the different ways of provirus delivery, we performed the same analysis in Jurkat T lymphocytes transfected with HIV proviral plasmids (Fig. 1D), that expressed higher levels of Gag and Nef than infected MT-4 cells. The presence of Nef resulted in a slightly more pronounced accumulation of Pr55Gag in the DRM fraction under these conditions (ratio of DRM-associated relative to total Gag: wt: 29.8%; ΔNef: 13.4%; PalmNef: 32.3%), suggesting that in Jurkat cells, Nef-mediated DRM recruitment by Nef is only observed upon transfection of proviral DNA. This most likely reflects the unphysiologically high levels of HIV-1 gene products per cell following provirus transfection. Thus, Nef-mediated recruitment of Gag into DRMs does not occur in the context of T lymphocyte infection and is dispensable for Nef's effects on virion infectivity.
Purification and characterization of HIV-1 virions
HIV-1 Nef increases the raft character of virus particles
HIV-1 Nef has no effect on the incorporation of cholesterol into HIV-1 particles
Besides SM, HIV-1 virions are also highly enriched in the unusual sphingolipid dihydrosphingomyelin (DHSM) and inhibition of sphingolipid synthesis resulted in a 5-fold reduction in virion infectivity . The magnitude of this effect is remarkable close to that Nef exerts on HIV-1 infectivity. However, when we determined the DHSM levels in HIV-1 virions produced in the absence of Nef, no significant change in DHSM virion incorporation was detected (data not shown). Together we conclude that the presence of Nef alters the PC species distribution and SM content of virus particles, while cholesterol and DHSM levels are unaffected.
Increase of virion SM levels by Nef is insufficient for elevating virion infectivity
Enhancement of virion infectivity by Nef is independent of DRM association of the viral entry receptor CD4
Nef modulates the lipid composition of DRMs in infected T lymphocytes
Building on our previous lipidome analysis of highly purified HIV-1 virions, this study tested the hypothesis that Nef affects the lipid composition of HIV-1 particles. Quantitative mass spectrometry indeed revealed that Nef underscores the microdomain character of the viral lipid envelope by increasing virion SM levels and reducing the amounts of polyunsaturated PC in HIV-1 particles. As these effects were also detected in DRM preparations from virus producing cells, the reported modulation of lipid composition of complex membrane bilayers adds a novel mechanism by which Nef can manipulate HIV-1 host cells.
Based on previous reports on the interaction with Nef and the resulting virion incorporation  we expected cholesterol to serve as a positive control for Nef effects in our lipidome analysis. Surprisingly however, we failed to detect any appreciable impact of Nef on virion cholesterol levels. These opposing results may reflect different experimental settings in both studies: Zheng et al. measured the uptake of radiolabeled cholesterol while in the present study overall cholesterol levels were quantified by highly sensitive nano-mass spectrometry. In line with our findings, we also failed to detect a physical interaction between Nef and cholesterol in solution by NMR spectroscopy. Such an interaction had been concluded from competition experiments of [17α-methyl-3H]-promegestone with water-soluble cholesterol . Using even higher concentrations of up to 800 μM water soluble cholesterol or cholesterol dissolved in ethanol we could not detect a specific interaction of cholesterol with Nef, however. In particular, no chemical shifts were observed for the putative C-terminal cholesterol binding motif L198HPEYYK in the presence of cholesterol (Fig. 4C). Irrespective of the basis for these differences, our results clearly demonstrate that Nef augments virion infectivity in the absence of elevating cholesterol levels of particles produced from infected T lymphocytes. Our study however does not exclude that Nef affects cholesterol homeostasis e.g. by upregulation of cholesterol biosynthesis genes [41, 42], which may not be reflected in bulk virion levels. Additionally, effects of Nef on cholesterol transport were recently reported in macrophages, where the interaction of Nef with the ABCA1 transporter and the resulting reduction of cholesterol efflux were suggested to be instrumental for Nef-mediated enhancement of virion infectivity . While this particular mechanism is not in place in T lymphocytes due to the lack of ABCA1 expression in this cell type, these results emphasize that Nef can affect lipid transport in HIV target cells.
Conflicting previous results caused a controversy as to whether the association of Nef with membrane microdomains contributes to its enhancement of virion infectivity [18, 21, 23]. We confirm here that in the context of T lymphocyte infection, Nef does not facilitate recruitment of HIV-1 Gag into DRMs and that an experimental increase in Nef's DRM association does not augment its effect on particle infectivity . The results presented also indicate that analysis of DRM incorporation of viral gene products following transfection of proviral DNA, which results in much higher copy numbers of these proteins per cell than following virus infection, should be interpreted with care. Even in the absence of elevated DRM recruitment of Gag, microdomain integrity is a prerequisite for Nef-mediated infectivity enhancement and specific disruption of Nef's microdomain association interferes with this activity [19, 23]. Together these results suggest that while microdomain association of Nef is critical for the positive effect of Nef on particle infectivity, this effect is already saturated at the physiological, moderate levels of Nef microdomain incorporation. Consistent with the well accepted model that Nef exerts its effects on virion infectivity during virus production , the viral protein augmented particle infectivity independently of whether virus entry occurred via microdomain targeted or excluded entry receptors. We cannot exclude that the microdomain association of the CD4 variants used changed upon engagement by the virus. Nevertheless our results are consistent with the concept that Nef modifies HIV-1 particles during production in a microdomain dependent manner to facilitate early, microdomain independent, post entry steps in the new target cells. Based on the low amounts of Nef present in microdomains, this scenario would be best compatible with a catalytic post entry event that is affected by Nef. In this context Qi and Aiken recently presented an intriguing model that predicts Nef to counteract proteasomal degradation of HIV-1 particles following entry into new target cells . Our analysis of Nef mutants revealed that the observed alterations in particle lipid composition were not sufficient to mediate Nef's effect on virion infectivity. However, as the ratio of e.g. cholesterol and SM critically determines the infectivity of HIV-1 particles [41, 42, 48, 49], these results do not exclude a contribution of the virion lipid composition to this Nef function. Such changes in lipid composition, possibly in conjunction with altered incorporation of host cell proteins, could thus affect post translational modifications and/or conformation of virion determinants that are recognized by the degradation machinery early post entry into a new target cell. This might also involve changes in the membrane microdomain organization of the virions, a parameter that is also critical for optimal particle infectivity [41, 42, 48, 49]. It will be of interest to understand in the future how microdomain association of Nef affects the early post entry fate of HIV virions in the recipient cell.
An important finding of this study is that Nef altered not only the lipid composition of HIV particles but also that of host cell membrane microdomains. Thus, in addition to the well established changes in microdomain protein composition [20, 40, 60], Nef also affects their lipid microenvironment. The overlap in changes induced by Nef on the lipid composition of bulk host cell microdomains and purified virions implies that the altered particle composition is a direct consequence of the modifications observed in the virus producing cell. The mechanism of this lipid modulatory activity of Nef as well as the molecular determinants for this activity remain unclear. In light of the effects of Nef on lipid transport discussed above, the lack of differences in the lipid composition in total cell lysates suggest effects of Nef on lipid sorting and/or microdomain incorporation as a major determinant of this function. Additionally, Nef may affect microdomain lipid composition by local changes in the turnover of select lipid classes e.g. via modulation of host cell signal transduction pathways and its direct association with lipid kinases such as PI3-K . As lipids potently regulate microdomain activitiy in membrane traffic and signal transduction , this mechanism could potentially contribute to a number of Nef's biological properties. The regulatory role of microdomain lipids is particularly prominent during T cell receptor signaling [32, 63–65], a process that is altered by Nef in a membrane microdomain dependent manner [19, 20, 39, 40]. Importantly, with Pak2 and PI3 kinases as well as the actin regulator Wasp, these effects of Nef involve its physical or functional association with cellular components whose activity is either subject to regulation by the local lipid microenvironment or causes alterations in the local lipid composition [66–68]. Finally, the altered lipid composition of microdomains in the presence of Nef might have direct consequences of protein incorporation into these domains . Future studies will focus on the functional consequences this novel lipid modulatory activity of Nef exhibits on host cell microdomain function.
This study describes alterations of the lipidome as a new activity of the HIV pathogenicity factor Nef that might contribute to its multifaceted strategies to manipulate HIV target cells for the optimization of virus spread in the infected host.
Reagents and plasmids
Isogenic proviral constructs expressing various nef genes based on the HIV-1 SF2 nef sequence in the backbone of the HIV-1 NL4-3 proviral clone were described earlier . The provirus encoding for a Nef protein with palmitoylation site (G3C mutation)  was constructed analogously. The complete nucleotide sequences of all nef inserts of these proviral clones were verified by sequencing of both DNA strands. The expression plasmids for wt CD4 and the 2Cm and 4C CD4 mutants were kindly provided by Dr. Jin and were described elsewhere . 2Cm lacks the palmitoylation acceptor in the cytoplasmic tail of CD4 while in 4C, the Lck interaction motif is additionally removed. Gag and Nef were detected using the polyclonal rabbit serum CA1 against p24CA  and the polyclonal anti-Nef sheep serum Arp444 , respectively. Antibodies against Env, RT, Vpr are described elsewhere .
Mass spectrometric lipid analysis of purified HIV particles
HIV-1 virions were purified from cell culture supernatants of infected MT-4 lymphocyte cultures and subjected to quantitative lipid analysis by nano-electrospray ionization tandem mass spectrometry, similarly as described .
For Western blot analysis, samples were boiled in SDS sample buffer, separated by 10% SDS-PAGE and transferred to a nitrocellulose membrane. Protein detection was performed following incubation with appropriate first and secondary antibodies using the super signal pico detection kit (Pierce, Bonn, Germany) according to the manufacturer's instructions.
HIV replication, single round infectivity, p24 ELISA
The relative infectivity of HIV-1 particles was determined by CA ELISA and a standardized 96 well TZM blue cell assay as described . Briefly, infections were carried out in triplicates with 0.5 ng CA input virus. 36 hours post infection, cells were fixed, stained for β-galactosidase activity and the number of blue cells was determined by microscopy. To analyze the effects of Nef on HIV replication in primary human T lymphocytes , peripheral blood mononuclear cells were isolated from healthy donors by Ficoll gradients using Ficoll-Paque Plus (Amersham Biosciences, Uppsala, Sweden). For infection, cells were thawed and kept in bulk cultures in RPMI, 10% FCS at 1 × 106 cells/ml over night. 1 × 105 cells/well were then seeded in V-bottom 96 well plates and infected with 1 ng CA virus input per well the following day. 3 days later, cells were washed and stimulated with 2 μg/ml PHA (Sigma) and 20 nM IL-2 (Chiron, Emeryville, CA) for 3 days. After stimulation, the PBL were washed and resuspended in 200 μl of RPMI containing FCS and IL-2. Each day, 100 μl of cell culture supernatant was replaced with fresh medium and amounts of CA in the cell culture supernatant were quantified to monitor virus replication using an in-house p24 ELISA .
15N,13C-labelled HIV-1 Nef-SF2 (Δ1–43, C210A) of HIV-1 was expressed and purified as described previously . The main-chain amide resonance assignments were taken from the HIV-1 Nef BH10 (Δ2–39, 159–173, C206A), whose structure was previously solved by high-resolution NMR spectroscopy . For binding studies 0.4 mM 15N,13C-labeled Nef (Δ1–43, C210A) was used in 5 mM Tris/HCl, pH 8.0, 5 mM DTE, 8% D2O, 92% H2O, and 0.05 mM DSS (4,4-dimethyl-4-silapentane-sulphonic acid). Cholesterol, water soluble cholesterol (cholesterol in methyl-β-cyclodextrin) and methyl-β-cyclodextrine were purchased from Sigma (C3045, C4951 and C4555, respectively), and used to prepare stock solutions of 40 mM cholesterol in ethanol, 7.5 mM water soluble cholesterol in 5 mM Tris/HCl buffer pH 8.0, and 7.5 mM methyl-β-cyclodextrine in the same buffer.
NMR measurements were performed at 308 K on Bruker Avance 800 MHz spectrometer operating at 800 MHz proton resonance frequency. 1H,15N-TROSY-HSQC were recorded as described by Pervushin et al. . The spectra were recorded with 4 K data points and a spectral width of 14 ppm in the 1H dimension, and with 128 data points and a spectral width of 40 ppm in the 15N dimension. Proton chemical shifts were referenced to DSS used as internal reference. The 15N chemical shifts were indirectly referenced to DSS using the frequency ratio given by Wishart et al. . Spectra were acquired and processed with Topspin 1.3 (Bruker Biospin, Karlsruhe), and analysed with the program AUREMOL .
Four identical 0.5 ml samples of 0.4 mM Nef solution were titrated with ethanol, cholesterol in ethanol, cyclodextrine and water soluble cholesterol. The total amount of protein was held constant. ethanol/cholesterol/cyclodextrine was added in increasing amounts up to a molar ratio of protein to ligand of 1 to 2.
We thank Dr. Yong-Jiu Jin for CD4 expression plasmids. This work was supported by grants from the Deutsche Forschungsgemeinschaft within Transregio 13 to O.T.F., F.T.W., B.B. and H.R.K., within SFB638 to H.G.K., as well as a group leader fellowship from the C.H.S. Stiftung to O.T.F.
- Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, et al: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 1995, 270 (5238): 988-991. 10.1126/science.270.5238.988.View ArticlePubMedGoogle Scholar
- Kestler HW, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 1991, 65 (4): 651-662. 10.1016/0092-8674(91)90097-I.View ArticlePubMedGoogle Scholar
- Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC: Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995, 332 (4): 228-232. 10.1056/NEJM199501263320405.View ArticlePubMedGoogle Scholar
- Geyer M, Fackler OT, Peterlin BM: Structure--function relationships in HIV-1 Nef. EMBO Rep. 2001, 2 (7): 580-585. 10.1093/embo-reports/kve141.PubMed CentralView ArticlePubMedGoogle Scholar
- Tolstrup M, Ostergaard L, Laursen AL, Pedersen SF, Duch M: HIV/SIV escape from immune surveillance: focus on Nef. Curr HIV Res. 2004, 2 (2): 141-151. 10.2174/1570162043484924.View ArticlePubMedGoogle Scholar
- Garcia JV, Miller AD: Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature. 1991, 350 (6318): 508-511. 10.1038/350508a0.View ArticlePubMedGoogle Scholar
- Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT: The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol. 2005, 15 (8): 714-723. 10.1016/j.cub.2005.02.058.View ArticlePubMedGoogle Scholar
- Roeth JF, Collins KL: Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev. 2006, 70 (2): 548-563. 10.1128/MMBR.00042-05.PubMed CentralView ArticlePubMedGoogle Scholar
- Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM: Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med. 1996, 2 (3): 338-342. 10.1038/nm0396-338.View ArticlePubMedGoogle Scholar
- Fackler OT, Alcover A, Schwartz O: Modulation of the immunological synapse: a key to HIV-1 pathogenesis?. Nat Rev Immunol. 2007, 7 (4): 310-317. 10.1038/nri2041.View ArticlePubMedGoogle Scholar
- Haller C, Rauch S, Michel N, Hannemann S, Lehmann MJ, Keppler OT, Fackler OT: The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J Biol Chem. 2006, 281 (28): 19618-19630. 10.1074/jbc.M513802200.View ArticlePubMedGoogle Scholar
- Schindler M, Munch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, Muller-Trutwin MC, Novembre FJ, Peeters M, Courgnaud V, Bailes E, Roques P, Sodora DL, Silvestri G, Sharp PM, Hahn BH, Kirchhoff F: Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell. 2006, 125 (6): 1055-1067. 10.1016/j.cell.2006.04.033.View ArticlePubMedGoogle Scholar
- Schrager JA, Marsh JW: HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci U S A. 1999, 96 (14): 8167-8172. 10.1073/pnas.96.14.8167.PubMed CentralView ArticlePubMedGoogle Scholar
- Thoulouze MI, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, Alcover A: Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity. 2006, 24 (5): 547-561. 10.1016/j.immuni.2006.02.016.View ArticlePubMedGoogle Scholar
- Aiken C, Trono D: Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol. 1995, 69 (8): 5048-5056.PubMed CentralPubMedGoogle Scholar
- Chowers MY, Spina CA, Kwoh TJ, Fitch NJ, Richman DD, Guatelli JC: Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol. 1994, 68 (5): 2906-2914.PubMed CentralPubMedGoogle Scholar
- Schwartz O, Marechal V, Danos O, Heard JM: Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol. 1995, 69 (7): 4053-4059.PubMed CentralPubMedGoogle Scholar
- Alexander M, Bor YC, Ravichandran KS, Hammarskjold ML, Rekosh D: Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity. J Virol. 2004, 78 (4): 1685-1696. 10.1128/JVI.78.4.1685-1696.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Giese SI, Woerz I, Homann S, Tibroni N, Geyer M, Fackler OT: Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology. 2006, 355 (2): 175-191. 10.1016/j.virol.2006.07.003.View ArticlePubMedGoogle Scholar
- Krautkramer E, Giese SI, Gasteier JE, Muranyi W, Fackler OT: Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J Virol. 2004, 78 (8): 4085-4097. 10.1128/JVI.78.8.4085-4097.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Sol-Foulon N, Esnault C, Percherancier Y, Porrot F, Metais-Cunha P, Bachelerie F, Schwartz O: The effects of HIV-1 Nef on CD4 surface expression and viral infectivity in lymphoid cells are independent of rafts. J Biol Chem. 2004, 279 (30): 31398-31408. 10.1074/jbc.M401621200.View ArticlePubMedGoogle Scholar
- Wang JK, Kiyokawa E, Verdin E, Trono D: The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci U S A. 2000, 97 (1): 394-399. 10.1073/pnas.97.1.394.PubMed CentralView ArticlePubMedGoogle Scholar
- Zheng YH, Plemenitas A, Linnemann T, Fackler OT, Peterlin BM: Nef increases infectivity of HIV via lipid rafts. Curr Biol. 2001, 11 (11): 875-879. 10.1016/S0960-9822(01)00237-8.View ArticlePubMedGoogle Scholar
- Rauch S, Fackler O: Viruses, lipid rafts and signal transduction. Signal Transduction. 2007, 7: 53-63. 10.1002/sita.200600113.View ArticleGoogle Scholar
- Chazal N, Gerlier D: Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev. 2003, 67 (2): 226-37, table of contents. 10.1128/MMBR.67.2.226-237.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, Puri A: Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol Membr Biol. 2003, 20 (3): 243-254. 10.1080/0968768031000104944.View ArticlePubMedGoogle Scholar
- Suomalainen M: Lipid rafts and assembly of enveloped viruses. Traffic. 2002, 3 (10): 705-709. 10.1034/j.1600-0854.2002.31002.x.View ArticlePubMedGoogle Scholar
- Mayor S, Rao M: Rafts: scale-dependent, active lipid organization at the cell surface. Traffic. 2004, 5 (4): 231-240. 10.1111/j.1600-0854.2004.00172.x.View ArticlePubMedGoogle Scholar
- Munro S: Lipid rafts: elusive or illusive?. Cell. 2003, 115 (4): 377-388. 10.1016/S0092-8674(03)00882-1.View ArticlePubMedGoogle Scholar
- Nichols B: Cell biology: without a raft. Nature. 2005, 436 (7051): 638-639. 10.1038/436638a.View ArticlePubMedGoogle Scholar
- Simons K, Ehehalt R: Cholesterol, lipid rafts, and disease. J Clin Invest. 2002, 110 (5): 597-603. 10.1172/JCI200216390.PubMed CentralView ArticlePubMedGoogle Scholar
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000, 1 (1): 31-39. 10.1038/35036052.View ArticlePubMedGoogle Scholar
- Gaus K, Chklovskaia E, Fazekas de St Groth B, Jessup W, Harder T: Condensation of the plasma membrane at the site of T lymphocyte activation. J Cell Biol. 2005, 171 (1): 121-131. 10.1083/jcb.200505047.PubMed CentralView ArticlePubMedGoogle Scholar
- Gaus K, Zech T, Harder T: Visualizing membrane microdomains by Laurdan 2-photon microscopy. Mol Membr Biol. 2006, 23 (1): 41-48. 10.1080/09687860500466857.View ArticlePubMedGoogle Scholar
- Plowman SJ, Muncke C, Parton RG, Hancock JF: H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc Natl Acad Sci U S A. 2005, 102 (43): 15500-15505. 10.1073/pnas.0504114102.PubMed CentralView ArticlePubMedGoogle Scholar
- Sharma P, Varma R, Sarasij RC, Ira, Gousset K, Krishnamoorthy G, Rao M, Mayor S: Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell. 2004, 116 (4): 577-589. 10.1016/S0092-8674(04)00167-9.View ArticlePubMedGoogle Scholar
- Douglass AD, Vale RD: Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell. 2005, 121 (6): 937-950. 10.1016/j.cell.2005.04.009.PubMed CentralView ArticlePubMedGoogle Scholar
- Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Krausslich HG: The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A. 2006, 103 (8): 2641-2646. 10.1073/pnas.0511136103.PubMed CentralView ArticlePubMedGoogle Scholar
- Pulkkinen K, Renkema GH, Kirchhoff F, Saksela K: Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J Virol. 2004, 78 (23): 12773-12780. 10.1128/JVI.78.23.12773-12780.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Simmons A, Gangadharan B, Hodges A, Sharrocks K, Prabhakar S, Garcia A, Dwek R, Zitzmann N, McMichael A: Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling. Immunity. 2005, 23 (6): 621-634. 10.1016/j.immuni.2005.11.003.View ArticlePubMedGoogle Scholar
- van 't Wout AB, Swain JV, Schindler M, Rao U, Pathmajeyan MS, Mullins JI, Kirchhoff F: Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virol. 2005, 79 (15): 10053-10058. 10.1128/JVI.79.15.10053-10058.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Zheng YH, Plemenitas A, Fielding CJ, Peterlin BM: Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc Natl Acad Sci U S A. 2003, 100 (14): 8460-8465. 10.1073/pnas.1437453100.PubMed CentralView ArticlePubMedGoogle Scholar
- Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, Mukhamedova N, Fu Y, Dart A, Orenstein JM, Bobryshev YV, Bukrinsky M, Sviridov D: Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006, 4 (11): e365-10.1371/journal.pbio.0040365.PubMed CentralView ArticlePubMedGoogle Scholar
- Tokunaga K, Kojima A, Kurata T, Ikuta K, Akari H, Koyama AH, Kawamura M, Inubushi R, Shimano R, Adachi A: Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent. J Gen Virol. 1998, 79 ( Pt 10): 2447-2453.View ArticleGoogle Scholar
- Tokunaga K, Kojima A, Kurata T, Ikuta K, Inubushi R, Shimano R, Kawamura M, Akari H, Koyama AH, Adachi A: Producer cell-dependent requirement of the Nef protein for efficient entry of HIV-1 into cells. Biochem Biophys Res Commun. 1998, 250 (3): 565-568. 10.1006/bbrc.1998.9346.View ArticlePubMedGoogle Scholar
- Welker R, Hohenberg H, Tessmer U, Huckhagel C, Krausslich HG: Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol. 2000, 74 (3): 1168-1177. 10.1128/JVI.74.3.1168-1177.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Grimm MO, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M, Tschape JA, De Strooper B, Muller U, Shen J, Hartmann T: Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol. 2005, 7 (11): 1118-1123.View ArticlePubMedGoogle Scholar
- Campbell S, Gaus K, Bittman R, Jessup W, Crowe S, Mak J: The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity. J Virol. 2004, 78 (19): 10556-10565. 10.1128/JVI.78.19.10556-10565.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Campbell SM, Crowe SM, Mak J: Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. Aids. 2002, 16 (17): 2253-2261. 10.1097/00002030-200211220-00004.View ArticlePubMedGoogle Scholar
- Fackler OT, Moris A, Tibroni N, Giese SI, Glass B, Schwartz O, Krausslich HG: Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology. 2006, 351 (2): 322-339. 10.1016/j.virol.2006.03.044.View ArticlePubMedGoogle Scholar
- Del Real G, Jimenez-Baranda S, Lacalle RA, Mira E, Lucas P, Gomez-Mouton C, Carrera AC, Martinez AC, Manes S: Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains. J Exp Med. 2002, 196 (3): 293-301. 10.1084/jem.20020308.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu NQ, Lossinsky AS, Popik W, Li X, Gujuluva C, Kriederman B, Roberts J, Pushkarsky T, Bukrinsky M, Witte M, Weinand M, Fiala M: Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol. 2002, 76 (13): 6689-6700. 10.1128/JVI.76.13.6689-6700.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Nguyen DH, Giri B, Collins G, Taub DD: Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res. 2005, 304 (2): 559-569. 10.1016/j.yexcr.2004.11.022.View ArticlePubMedGoogle Scholar
- Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier JL, Arenzana-Seisdedos F, Hoessli DC, Bachelerie F: HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J Biol Chem. 2003, 278 (5): 3153-3161. 10.1074/jbc.M207371200.View ArticlePubMedGoogle Scholar
- Popik W, Alce TM: CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. J Biol Chem. 2004, 279 (1): 704-712. 10.1074/jbc.M306380200.View ArticlePubMedGoogle Scholar
- Popik W, Alce TM, Au WC: Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol. 2002, 76 (10): 4709-4722. 10.1128/JVI.76.10.4709-4722.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Fragoso R, Ren D, Zhang X, Su MW, Burakoff SJ, Jin YJ: Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol. 2003, 170 (2): 913-921.View ArticlePubMedGoogle Scholar
- Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, Guatelli JC: Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol. 1996, 70 (7): 4283-4290.PubMed CentralPubMedGoogle Scholar
- Qi M, Aiken C: Selective restriction of Nef-defective human immunodeficiency virus type 1 by a proteasome-dependent mechanism. J Virol. 2007, 81 (3): 1534-1536. 10.1128/JVI.02099-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Djordjevic JT, Schibeci SD, Stewart GJ, Williamson P: HIV type 1 Nef increases the association of T cell receptor (TCR)-signaling molecules with T cell rafts and promotes activation-induced raft fusion. AIDS Res Hum Retroviruses. 2004, 20 (5): 547-555. 10.1089/088922204323087804.View ArticlePubMedGoogle Scholar
- Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G: HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell. 2002, 111 (6): 853-866. 10.1016/S0092-8674(02)01162-5.View ArticlePubMedGoogle Scholar
- Krauss M, Haucke V: Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling. EMBO Rep. 2007, 8 (3): 241-246. 10.1038/sj.embor.7400919.PubMed CentralView ArticlePubMedGoogle Scholar
- Kabouridis PS: Lipid rafts in T cell receptor signalling. Mol Membr Biol. 2006, 23 (1): 49-57. 10.1080/09687860500453673.PubMed CentralView ArticlePubMedGoogle Scholar
- Geyeregger R, Zeyda M, Zlabinger GJ, Waldhausl W, Stulnig TM: Polyunsaturated fatty acids interfere with formation of the immunological synapse. J Leukoc Biol. 2005, 77 (5): 680-688. 10.1189/jlb.1104687.View ArticlePubMedGoogle Scholar
- Zeyda M, Szekeres AB, Saemann MD, Geyeregger R, Stockinger H, Zlabinger GJ, Waldhausl W, Stulnig TM: Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation. J Immunol. 2003, 170 (12): 6033-6039.View ArticlePubMedGoogle Scholar
- Bokoch GM, Reilly AM, Daniels RH, King CC, Olivera A, Spiegel S, Knaus UG: A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids. J Biol Chem. 1998, 273 (14): 8137-8144. 10.1074/jbc.273.14.8137.View ArticlePubMedGoogle Scholar
- Papayannopoulos V, Co C, Prehoda KE, Snapper S, Taunton J, Lim WA: A polybasic motif allows N-WASP to act as a sensor of PIP(2) density. Mol Cell. 2005, 17 (2): 181-191. 10.1016/j.molcel.2004.11.054.View ArticlePubMedGoogle Scholar
- Hawkins PT, Anderson KE, Davidson K, Stephens LR: Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans. 2006, 34 (Pt 5): 647-662.View ArticlePubMedGoogle Scholar
- Zeyda M, Staffler G, Horejsi V, Waldhausl W, Stulnig TM: LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty acids. J Biol Chem. 2002, 277 (32): 28418-28423. 10.1074/jbc.M203343200.View ArticlePubMedGoogle Scholar
- Muller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, Krausslich HG: Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J Virol. 2004, 78 (19): 10803-10813. 10.1128/JVI.78.19.10803-10813.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Coates K, Cooke SJ, Mann DA, Harris MP: Protein kinase C-mediated phosphorylation of HIV-I nef in human cell lines. J Biol Chem. 1997, 272 (19): 12289-12294. 10.1074/jbc.272.19.12289.View ArticlePubMedGoogle Scholar
- Keppler OT, Allespach I, Schuller L, Fenard D, Greene WC, Fackler OT: Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J Virol. 2005, 79 (3): 1655-1665. 10.1128/JVI.79.3.1655-1665.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Breuer S, Gerlach H, Kolaric B, Urbanke C, Opitz N, Geyer M: Biochemical Indication for Myristoylation-Dependent Conformational Changes in HIV-1 Nef. Biochemistry. 2006, 45 (7): 2339-2349. 10.1021/bi052052c.View ArticlePubMedGoogle Scholar
- Grzesiek S, Bax A, Hu JS, Kaufman J, Palmer I, Stahl SJ, Tjandra N, Wingfield PT: Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Sci. 1997, 6 (6): 1248-1263.PubMed CentralView ArticlePubMedGoogle Scholar
- Pervushin K, Riek R, Wider G, Wuthrich K: Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci U S A. 1997, 94 (23): 12366-12371. 10.1073/pnas.94.23.12366.PubMed CentralView ArticlePubMedGoogle Scholar
- Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL, Sykes BD: 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR. 1995, 6 (2): 135-140. 10.1007/BF00211777.View ArticlePubMedGoogle Scholar
- Gronwald W, Kalbitzer HR: Automated Structure Determination of Proteins by NMR Spectroscopy. Progr NMR Spectr. 2004, 44: 33-96. 10.1016/j.pnmrs.2003.12.002.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.